These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 29398328)

  • 1. Relation of asymmetrical dimethylarginine levels with renal outcomes in hypertensive patients with and without type 2 diabetes mellitus.
    Triches CB; Quinto M; Mayer S; Batista M; Zanella MT
    J Diabetes Complications; 2018 Mar; 32(3):316-320. PubMed ID: 29398328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of endothelial dysfunction with cardiovascular risk factors and new-onset diabetes mellitus in patients with hypertension.
    Triches CB; Mayer S; Quinto BMR; Batista MC; Zanella MT
    J Clin Hypertens (Greenwich); 2018 May; 20(5):935-941. PubMed ID: 29604155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic renal impairment and DDAH2-1151 A/C polymorphism determine ADMA levels in type 2 diabetic subjects.
    Marra M; Marchegiani F; Ceriello A; Sirolla C; Boemi M; Franceschi C; Spazzafumo L; Testa I; Bonfigli AR; Cucchi M; Testa R
    Nephrol Dial Transplant; 2013 Apr; 28(4):964-71. PubMed ID: 23129820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Asymmetrical dimethylarginine is related to renal function, chronic inflammation and macroangiopathy in patients with Type 2 diabetes and albuminuria.
    Krzyzanowska K; Mittermayer F; Shnawa N; Hofer M; Schnabler J; Etmüller Y; Kapiotis S; Wolzt M; Schernthaner G
    Diabet Med; 2007 Jan; 24(1):81-6. PubMed ID: 17227328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum asymmetric dimethylarginine and arginine levels predict microvascular and macrovascular complications in type 2 diabetes mellitus.
    Ganz T; Wainstein J; Gilad S; Limor R; Boaz M; Stern N
    Diabetes Metab Res Rev; 2017 Feb; 33(2):. PubMed ID: 27393712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Symmetric dimethylarginine (SDMA) outperforms asymmetric dimethylarginine (ADMA) and other methylarginines as predictor of renal and cardiovascular outcome in non-dialysis chronic kidney disease.
    Emrich IE; Zawada AM; Martens-Lobenhoffer J; Fliser D; Wagenpfeil S; Heine GH; Bode-Böger SM
    Clin Res Cardiol; 2018 Mar; 107(3):201-213. PubMed ID: 29101459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A study of endothelial function and circulating asymmetric dimethylarginine levels in people with Type 1 diabetes without macrovascular disease or microalbuminuria.
    Sibal L; Agarwal SC; Schwedhelm E; Lüneburg N; Böger RH; Home PD
    Cardiovasc Diabetol; 2009 Jun; 8():27. PubMed ID: 19486510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma concentration of asymmetric dimethylarginine (ADMA) predicts cardiovascular morbidity and mortality in type 1 diabetic patients with diabetic nephropathy.
    Lajer M; Tarnow L; Jorsal A; Teerlink T; Parving HH; Rossing P
    Diabetes Care; 2008 Apr; 31(4):747-52. PubMed ID: 18162497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Asymmetric dimethylarginine is closely associated with the development and progression of nephropathy in patients with type 2 diabetes.
    Hanai K; Babazono T; Nyumura I; Toya K; Tanaka N; Tanaka M; Ishii A; Iwamoto Y
    Nephrol Dial Transplant; 2009 Jun; 24(6):1884-8. PubMed ID: 19131352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of nebivolol and metoprolol treatments on serum asymmetric dimethylarginine levels in hypertensive patients with type 2 diabetes mellitus.
    Oğuz A; Uzunlulu M; Yorulmaz E; Yalçin Y; Hekim N; Fici F
    Anadolu Kardiyol Derg; 2007 Dec; 7(4):383-7. PubMed ID: 18065333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interrelationship of Multiple Endothelial Dysfunction Biomarkers with Chronic Kidney Disease.
    Chen J; Hamm LL; Mohler ER; Hudaihed A; Arora R; Chen CS; Liu Y; Browne G; Mills KT; Kleinpeter MA; Simon EE; Rifai N; Klag MJ; He J
    PLoS One; 2015; 10(7):e0132047. PubMed ID: 26132137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Time course of asymmetric dimethylarginine and symmetric dimethylarginine levels after successful renal transplantation.
    Claes KJ; Bammens B; Kuypers DR; Meijers B; Naesens M; Sprangers B; Vanrenterghem Y; Lerut E; de Loor H; Evenepoel P
    Nephrol Dial Transplant; 2014 Oct; 29(10):1965-72. PubMed ID: 24957811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of circulatory asymmetric dimethylarginine (ADMA) with diabetic nephropathy in Asian Indians and its causative role in renal cell injury.
    Jayachandran I; Sundararajan S; Paramasivam P; Venkatesan B; Subramanian SC; Balasubramanyam M; Mohan V; Manickam N
    Clin Biochem; 2017 Oct; 50(15):835-842. PubMed ID: 28495185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Asymmetric dimethylarginine and clinical outcomes in chronic kidney disease.
    Lu TM; Chung MY; Lin CC; Hsu CP; Lin SJ
    Clin J Am Soc Nephrol; 2011 Jul; 6(7):1566-72. PubMed ID: 21642363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ADMA, SDMA and L-arginine/ADMA ratio but not DDAH genetic polymorphisms are reliable predictors of diabetic nephropathy progression as identified by competing risk analysis.
    Tanhäuserová V; Tomandl J; Pácal L; Klepárník M; Malúšková D; Bartáková V; Kuricová K; Rehořová J; Stěpánková S; Svojanovský J; Olšovský J; Bělobrádková J; Krusová D; Jurajda M; Mužík J; Pavlík T; Kaňková K
    Kidney Blood Press Res; 2012; 36(1):200-8. PubMed ID: 23147199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Significance of the factors of hypoxia and endothelial dysfunction in kidney injury in the presence of obesity].
    Galiamov MG; Saginova EA; Severova MM; Samokhodskaia LM; Krasnova TN; Sholomova VI; Sorokin IuD; Mukhin NA
    Ter Arkh; 2013; 85(6):31-7. PubMed ID: 23866596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The value of serum asymmetric dimethylarginine levels for the determination of masked hypertension in patients with diabetes mellitus.
    Taner A; Unlu A; Kayrak M; Tekinalp M; Ayhan SS; Arıbaş A; Erdem SS
    Atherosclerosis; 2013 Jun; 228(2):432-7. PubMed ID: 23540293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. L-arginine, NO and asymmetrical dimethylarginine in hypertension and type 2 diabetes.
    Das UN; Repossi G; Dain A; Eynard AR
    Front Biosci (Landmark Ed); 2011 Jan; 16(1):13-20. PubMed ID: 21196155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma concentrations of asymmetric-dimethyl-arginine in type 2 diabetes associate with glycemic control and glomerular filtration rate but not with risk factors of vasculopathy.
    Päivä H; Lehtimäki T; Laakso J; Ruokonen I; Rantalaiho V; Wirta O; Pasternack A; Laaksonen R
    Metabolism; 2003 Mar; 52(3):303-7. PubMed ID: 12647267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The combined ratios of L-arginine and asymmetric and symmetric dimethylarginine as biomarkers in spontaneously hypertensive rats.
    Hsu CN; Huang LT; Lau YT; Lin CY; Tain YL
    Transl Res; 2012 Feb; 159(2):90-8. PubMed ID: 22243793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.